Premium
Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia‐response and RNA processing functions
Author(s) -
Raman Rohini,
Allen Scott P,
Goodall Emily F,
Kramer Shelley,
Ponger LizeLinde,
Heath Paul R.,
Milo Marta,
Hollinger Hannah C.,
Walsh Theresa,
Highley J Robin,
Olpin Simon,
McDermott Christopher J.,
Shaw Pamela J.,
Kirby Janine
Publication year - 2015
Publication title -
neuropathology and applied neurobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.538
H-Index - 95
eISSN - 1365-2990
pISSN - 0305-1846
DOI - 10.1111/nan.12147
Subject(s) - hypoxia (environmental) , gene expression , rna , biology , gene , microbiology and biotechnology , metabolism , neuroscience , motor neurone disease , disease , chemistry , pathology , medicine , endocrinology , genetics , amyotrophic lateral sclerosis , oxygen , organic chemistry
Aims Amyotrophic lateral sclerosis ( ALS ) and primary lateral sclerosis ( PLS ) are two syndromic variants within the motor neurone disease spectrum. As PLS and most ALS cases are sporadic ( SALS ), this limits the availability of cellular models for investigating pathogenic mechanisms and therapeutic targets. The aim of this study was to use gene expression profiling to evaluate fibroblasts as cellular models for SALS and PLS , to establish whether dysregulated biological processes recapitulate those seen in the central nervous system and to elucidate pathways that distinguish the clinically defined variants of SALS and PLS . Methods Microarray analysis was performed on fibroblast RNA and differentially expressed genes identified. Genes in enriched biological pathways were validated by quantitative PCR and functional assays performed to establish the effect of altered RNA levels on the cellular processes. Results Gene expression profiling demonstrated that whilst there were many differentially expressed genes in common between SALS and PLS fibroblasts, there were many more expressed specifically in the SALS fibroblasts, including those involved in RNA processing and the stress response. Functional analysis of the fibroblasts confirmed a significant decrease in miRNA production and a reduced response to hypoxia in SALS fibroblasts. Furthermore, metabolic gene changes seen in SALS , many of which were also evident in PLS fibroblasts, resulted in dysfunctional cellular respiration. Conclusions The data demonstrate that fibroblasts can act as cellular models for ALS and PLS , by establishing the transcriptional changes in known pathogenic pathways that confer subsequent functional effects and potentially highlight targets for therapeutic intervention.